Abstract
In major depression (MDD), hospital treatment is an option in more severe cases or if outpatient treatment failed. Psychosomatic hospitals in Germany provide treatment programs with multimodal psychotherapy, either in an inpatient or a day hospital setting. In the context of health care research, this study aimed (1) to compare characteristics of patients treated in psychosomatic day hospitals and inpatient units, (2) to compare the effectiveness of both treatment modalities. A naturalistic design was chosen to achieve external validity. 604 consecutive patients were assessed at admission, discharge and a 3-month follow-up. Primary outcome was defined as a reduction of depressive symptomatology (QIDS-C), secondary outcomes comprise overall functioning and quality of life. For a comparison of effectiveness, inpatient and day hospital samples were matched according to known predictors of outcome. The few differences found between the inpatient and day hospital sample were related to severity of depression and physical impairment. Inpatients more often got antidepressant medication. Additionally, inpatients were treated significantly longer, due to a subgroup of patients with somatic co-morbidity. There were no differences when co...Continue Reading
References
Sep 1, 1992·The American Journal of Psychiatry·H H GoldmanT R Lave
Feb 1, 1996·The British Journal of Clinical Psychology·M BarkhamM Startup
Dec 31, 1997·Journal of Personality Disorders·C MaffeiM Petrachi
Aug 30, 2003·Biological Psychiatry·A John RushMartin B Keller
Apr 22, 2004·Psychological Medicine·F JacobiR Lieb
Jun 28, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Klaus-Peter SeidlerHorst Haltenhof
May 4, 2007·The American Journal of Psychiatry·Elisabeth SchrammMathias Berger
Sep 26, 2008·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Kathrin Mörtl, Jörn Von Wietersheim
Jul 25, 2009·Psychotherapy and Psychosomatics·Almut ZeeckArmin Hartmann
Jan 26, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Florian SeemüllerHans-Jürgen Möller
May 7, 2010·CNS Drugs·Giovanni A Fava, Elena Tomba
Dec 15, 2010·Journal of Affective Disorders·Sarah C WoodersonAnthony J Cleare
Jul 28, 2012·Trials·Manfred E BeutelMartin Hautzinger
Jan 9, 2013·Psychotherapy and Psychosomatics·Jack DekkerJaap Peen
Mar 28, 2013·BMC Psychiatry·Almut ZeeckArmin Hartmann
Sep 14, 2013·The American Journal of Psychiatry·Ellen DriessenJack J M Dekker
Feb 5, 2014·Journal of Consulting and Clinical Psychology·Scott A BaldwinDavid C Atkins
Apr 1, 2014·Journal of Affective Disorders·Pim CuijpersAnnemieke van Straten
Apr 23, 2014·Psychotherapy and Psychosomatics·Ulrike DingerHenning Schauenburg
Jul 12, 2014·Journal of Affective Disorders·Sarah C WoodersonAnthony J Cleare
Aug 21, 2014·PloS One·Sarah Liebherz, Sven Rabung
Jan 2, 2015·Journal of Affective Disorders·Karolien E M Biesheuvel-LeliefeldFilip Smit
Citations
Mar 21, 2016·Journal of Affective Disorders·Almut ZeeckArmin Hartmann
Oct 28, 2019·Journal of Medical Internet Research·Rüdiger ZwerenzManfred E Beutel
Aug 25, 2020·Der Nervenarzt·Carmen UhlmannPetra Schmid
Jun 12, 2018·Dementia·Alexandra LinnemannAndreas Fellgiebel
Apr 1, 2020·Frontiers in Psychiatry·Almut ZeeckArmin Hartmann
Aug 28, 2020·Frontiers in Psychiatry·Lukas WeißUNKNOWN INDDEP Study Group
Jun 4, 2019·Zeitschrift für Psychosomatische Medizin und Psychotherapie·Daniel SeidlerMatthias Franz
Jan 16, 2021·Psychotherapie, Psychosomatik, medizinische Psychologie·Daniel SeidlerMatthias Franz
Jun 5, 2019·Revista de psiquiatrí́a y salud mental·Javier Vázquez-BourgonBenedicto Crespo Facorro
Dec 11, 2019·Psychotherapie, Psychosomatik, medizinische Psychologie·Jörn von WietersheimAlmut Zeeck
Nov 29, 2016·Journal of Affective Disorders·Yves de RotenJean-Nicolas Despland